Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Company Info
No authors found
0 Contributors
1 / 0
1 / 0
Visit the Website
Spirovant Sciences
Other
Overview
1 Contributions
1 / 1
1 / 1
Cystic Fibrosis
Spirovant Sciences Doses First Patient in Phase 1/2 Trial of Its Aerosol-Delivered Genetic Medicine for Treating Cystic Fibrosis
Spirovant Sciences
PR-11-24-NI-101
Nov 15, 2024
